A FDA panel is considering a new kind of flu vaccine, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic. The vaccine has the potential to provide better protection against the flu, and could be a game-changer for Buffalo residents.
"This vaccine has the potential to provide better protection against the flu, and could be a game-changer for public health," said a FDA official. The vaccine is still in the experimental stages, but if approved, it could be available to Buffalo residents as early as next flu season.
The FDA panel is debating the vaccine's safety and effectiveness, and will make a decision in the coming weeks. In Buffalo, parents in the Williamsville district are watching the developments closely, as they consider the best ways to protect their children from the flu. The FDA has a long history of approving safe and effective vaccines, and Buffalo residents can trust that the agency will make a decision based on the best available science.
The vaccine has the potential to reduce the number of flu cases in Buffalo, and could be especially beneficial for vulnerable populations such as the elderly and young children. Small business owners on Hertel Ave can also breathe a sigh of relief, as a reduction in flu cases could mean fewer missed workdays and increased productivity. The FDA panel will continue to review the data and make a decision on the vaccine's approval.
The decision is expected to be made by the end of July, and Buffalo residents can expect to hear more about the vaccine in the coming weeks.